The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Open accessAbstract
Systemic and local chronic inflammation might enhance the risk of pancreatic ductal adenocarcinoma (PDAC), and PDAC-associated inflammatory infiltrate in the tumor microenvironment concurs in enhancing tumor growth and metastasis. Inflammation is closely correlated with immunity, the same immune cell populations contributing to both inflammation and immune response. In the PDAC microenvironment, the inflammatory cell infiltrate is unbalanced towards an immunosuppressive phenotype, with a prevalence of myeloid derived suppressor cells (MDSC), M2 polarized macrophages, and Treg, over M1 macrophages, dendritic cells, and effector CD4+ and CD8+ T lymphocytes. The dynamic and continuously evolving cross-talk between inflammatory and cancer cells might be direct and contact-dependent, but it is mainly mediated by soluble and exosomes-carried cytokines. Among these, tumor necrosis factor alpha (TNFα) plays a relevant role in enhancing cancer risk, cancer growth, and cancer-associated cachexia. In this review, we describe the inflammatory cell types, the cytokines, and the mechanisms underlying PDAC risk, growth, and progression, with particular attention on TNFα, also in the light of the potential risks or benefits associated with anti-TNFα treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621 · cited 1×
“This highly metastatic burden and the associated poor survival depend on PDAC genetics, but also on the types of stromal infiltrating immune cells [53].”
BackgroundDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Initiative, A. P. C. G., Balachandran, V. P., Łuksza, M., Zhao, J. N., Makarov, V., Moral, J. A., Remark, R., Herbst, B., Askan, G., Bhanot, U., et al. (2017) · Nature · doi:10.1038/nature24462 · Cited by 1,191
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Rothwell, P. M., Wilson, M., Price, J. F., Belch, J. F., Meade, T. W., & Mehta, Z. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60209-8 · Cited by 984
Optimizing the outcomes of pancreatic cancer surgery
Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0112-1 · Cited by 943
Cani, P. D., Osto, M., Geurts, L., & Everard, A. (2012) · Gut Microbes · doi:10.4161/gmic.19625 · Cited by 864
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Meta-analyses of colorectal cancer risk factors
Johnson, C. M., Wei, C., Ensor, J. E., Smolenski, D. J., Amos, C. I., Levin, B., & Berry, D. A. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0201-5 · Cited by 779
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 742
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706
Carstens, J. L., Correa de Sampaio, P., Yang, D., Barua, S., Wang, H., Rao, A., Allison, J. P., LeBleu, V. S., & Kalluri, R. (2017) · Nature Communications · doi:10.1038/ncomms15095 · Cited by 633
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621 · cited 1×
“On the other hand, PDAC itself is known to cause diabetes mellitus by reducing insulin release, enhancing insulin resistance, and leading to new onset diabetes mellitus, which is diagnosed in more than 60% of patients with this tumor type [28,29].”
BackgroundAnti-TNF therapy: past, present and future
Monaco, C., Nanchahal, J., Taylor, P., & Feldmann, M. (2015) · International Immunology · doi:10.1093/intimm/dxu102 · Cited by 581
Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis
Kirkegård, J., Mortensen, F. V., & Cronin-Fenton, D. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.218 · Cited by 535
Diabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
Wu, D., Hu, D., Chen, H., Shi, G., Fetahu, I. S., Wu, F., Rabidou, K., Fang, R., Tan, L., Xu, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0350-5 · Cited by 477 · cited 1×
“[31], glucose itself has a potential oncogenic effect, as it destabilizes the tumor suppressive function of ten-eleven translocation protein 2 (TET2) involved in DNA methylation.”
BackgroundNutrition, inflammation and cancer
Zitvogel, L., Pietrocola, F., & Kroemer, G. (2017) · Nature Immunology · doi:10.1038/ni.3754 · Cited by 446 · cited 3×
“triggered to protect the organism against loss of tissue homeostasis, is involved in several steps of the carcinogenetic process [16].”
BackgroundLi, W., Tanikawa, T., Kryczek, I., Xia, H., Li, G., Wu, K., Wei, S., Zhao, L., Vatan, L., Wen, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.022 · Cited by 446
McAllister, F., Bailey, J. M., Alsina, J., Nirschl, C. J., Sharma, R., Fan, H., Rattigan, Y., Roeser, J. C., Lankapalli, R. H., Zhang, H., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.014 · Cited by 405
Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms
Basso, D., Zambon, C., Letley, D. P., Stranges, A., Marchet, A., Rhead, J. L., Schiavon, S., Guariso, G., Ceroti, M., Nitti, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.041 · Cited by 405
Self-citationThe role of stromal cancer-associated fibroblasts in pancreatic cancer
von Ahrens, D., Bhagat, T. D., Nagrath, D., Maitra, A., & Verma, A. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0448-5 · Cited by 389
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
Cani, P. D., & Jordan, B. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0025-6 · Cited by 383
Jang, J.-E., Hajdu, C. H., Liot, C., Miller, G., Dustin, M. L., & Bar-Sagi, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.062 · Cited by 372
A meta-analysis of obesity and the risk of pancreatic cancer
de Gonzalez, A. B., Sweetland, S., & Spencer, E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601140 · Cited by 347
TNF-α and cancer cachexia: Molecular insights and clinical implications
Patel, H. J., & Patel, B. M. (2017) · Life Sciences · doi:10.1016/j.lfs.2016.11.033 · Cited by 342
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Petruzzelli, M., & Wagner, E. F. (2016) · Genes & Development · doi:10.1101/gad.276733.115 · Cited by 340
Askling, J., Fahrbach, K., Nordstrom, B., Ross, S., Schmid, C. H., & Symmons, D. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2046 · Cited by 301
Lopez-Olivo, M. A., Tayar, J. H., Martinez-Lopez, J. A., Pollono, E. N., Cueto, J. P., Gonzales-Crespo, M. R., Fulton, S., & Suarez-Almazor, M. E. (2012) · JAMA · doi:10.1001/2012.jama.10857 · Cited by 295
The Immune Revolution: A Case for Priming, Not Checkpoint
Vonderheide, R. H. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.008 · Cited by 293
Bosetti, C., Rosato, V., Li, D., Silverman, D., Petersen, G. M., Bracci, P. M., Neale, R. E., Muscat, J., Anderson, K., Gallinger, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu276 · Cited by 283
Porembka, M. R., Mitchem, J. B., Belt, B. A., Hsieh, C.-S., Lee, H.-M., Herndon, J., Gillanders, W. E., Linehan, D. C., & Goedegebuure, P. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1178-0 · Cited by 277
TNF Counterbalances the Emergence of M2 Tumor Macrophages
Kratochvill, F., Neale, G., Haverkamp, J. M., Van de Velde, L.-A., Smith, A. M., Kawauchi, D., McEvoy, J., Roussel, M. F., Dyer, M. A., Qualls, J. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.033 · Cited by 277
Helm, O., Held‐Feindt, J., Grage‐Griebenow, E., Reiling, N., Ungefroren, H., Vogel, I., Krüger, U., Becker, T., Ebsen, M., Röcken, C., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28736 · Cited by 260
Anti–Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Egberts, J.-H., Cloosters, V., Noack, A., Schniewind, B., Thon, L., Klose, S., Kettler, B., von Forstner, C., Kneitz, C., Tepel, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5704 · Cited by 259
Advanced-stage pancreatic cancer: therapy options
Werner, J., Combs, S. E., Springfeld, C., Hartwig, W., Hackert, T., & Büchler, M. W. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.66 · Cited by 218
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
Li, D., Tang, H., Hassan, M. M., Holly, E. A., Bracci, P. M., & Silverman, D. T. (2011) · Cancer Causes & Control · doi:10.1007/s10552-010-9686-3 · Cited by 215
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
Stevens, R. J., Roddam, A. W., & Beral, V (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603571 · Cited by 194
Meta-analysis of radical resection rates and margin assessment in pancreatic cancer
Chandrasegaram, M. D., Goldstein, D., Simes, J., Gebski, V, Kench, J. G., Gill, A. J., Samra, J. S., Merrett, N. D., Richardson, A. J., & Barbour, A. P. (2015) · British Journal of Surgery · doi:10.1002/bjs.9892 · Cited by 188
Herman, J. M., Wild, A. T., Wang, H., Tran, P. T., Chang, K. J., Taylor, G. E., Donehower, R. C., Pawlik, T. M., Ziegler, M. A., Cai, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.7516 · Cited by 186
Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies
Batabyal, P., Vander Hoorn, S., Christophi, C., & Nikfarjam, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3625-6 · Cited by 183
NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development
Ratnam, N. M., Peterson, J. M., Talbert, E. E., Ladner, K. J., Rajasekera, P. V., Schmidt, C. R., Dillhoff, M. E., Swanson, B. J., Haverick, E., Kladney, R. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91561 · Cited by 175
Sideras, K., Braat, H., Kwekkeboom, J., van Eijck, C. H., Peppelenbosch, M. P., Sleijfer, S., & Bruno, M. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.005 · Cited by 173
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncogene · doi:10.1038/onc.2016.107 · Cited by 173
Williams, C. J. M., Peyrin‐Biroulet, L., & Ford, A. C. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12624 · Cited by 171
Castro-Villegas, C., Pérez-Sánchez, C., Escudero, A., Filipescu, I., Verdu, M., Ruiz-Limón, P., Aguirre, M. A., Jiménez-Gomez, Y., Font, P., Rodriguez-Ariza, A., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0555-z · Cited by 166
Inflammatory cytokines in human pancreatic cancer
Roshani, R., McCarthy, F. M., & Hagemann, T. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.014 · Cited by 163
Zhou, Y., Wei, Q., Fan, J., Cheng, S., Ding, W., & Hua, Z. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.024 · Cited by 163
Complex role for the immune system in initiation and progression of pancreatic cancer
Inman, K. S., Francis, A. A., & Murray, N. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11160 · Cited by 158
Steeland, S., Libert, C., & Vandenbroucke, R. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051442 · Cited by 156
Zhang, Y., Zoltan, M. A., Riquelme, E. M., Xu, H., Şahin, İ., Castro-Pando, S., Montiel, M. F., Chang, K., Jiang, Z., Ling, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.041 · Cited by 154
Nutrient Competition: A New Axis of Tumor Immunosuppression
Sukumar, M., Roychoudhuri, R., & Restifo, N. P. (2015) · Cell · doi:10.1016/j.cell.2015.08.064 · Cited by 142
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
Ottaviani, S., Stebbing, J., Frampton, A. E., Zagorac, S., Krell, J., de Giorgio, A., Trabulo, S. M. D., Nguyen, V. T. M., Magnani, L., Feng, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03962-x · Cited by 139
Elena, J. W., Steplowski, E., Yu, K. F., Hartge, P. A., Tobias, G. S., Brotzman, M. J., Chanock, S. J., Stolzenberg‐Solomon, R. Z., Arslan, A. A., Bueno-de-Mesquita, H. B., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0078-8 · Cited by 137
Eisenblätter, M., Flores‐Borja, F., Lee, J. J., Wefers, C., Smith, H. L., Hueting, R., Cooper, M. S., Blower, P. J., Patel, D., Rodriguez‐Justo, M., et al. (2017) · Theranostics · doi:10.7150/thno.17138 · Cited by 130
Loncle, C., Bonjoch, L., Folch‐Puy, E., López‐Millán, B., Lac, S., Molejon, M. I., Chuluyán, E., Cordelier, P., Dubus, P. R., Lomberk, G. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0896 · Cited by 123
Karakhanova, S., Link, J., Heinrich, M., Shevchenko, I., Yang, Y., Hassenpflug, M., Bunge, H., von Ahn, K., Brecht, R., Mathes, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.998519 · Cited by 118
Myeloid-derived suppressor cells and their role in pancreatic cancer
Pergamo, M., & Miller, G. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.65 · Cited by 115
Pang, Y., Kartsonaki, C., Guo, Y., Bragg, F., Yang, L., Bian, Z., Chen, Y., Iona, A., Millwood, I. Y., Lv, J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30599 · Cited by 108
Pivarcsi, A., Meisgen, F., Xu, N., Ståhle, M., & Sonkoly, E. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12381 · Cited by 105
The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
Costello, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00270 · Cited by 102
The Healthy Eating Index 2005 and Risk for Pancreatic Cancer in the NIH-AARP Study
Arem, H. E., Reedy, J., Sampson, J. N., Jiao, L., Hollenbeck, A. R., Risch, H. A., Mayne, S. T., & Stolzenberg‐Solomon, R. Z. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt185 · Cited by 102
Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice
Panebianco, C., Adamberg, K., Jaagura, M., Copetti, M., Fontana, A., Adamberg, S., Kolk, K., Vilu, R., Andriulli, A., & Pazienza, V. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3549-0 · Cited by 101
Zhao, X., Fan, W., Xu, Z., Chen, H., He, Y., Yang, G. F., Yang, G., Hu, H., Tang, S., Wang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13212 · Cited by 95
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review
Yako, Y. Y., Kruger, D., Smith, M., & Brand, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154016 · Cited by 89
IL-6 roles – Molecular pathway and clinical implication in pancreatic cancer – A systemic review
Pop, V.-V., Seicean, A., Lupan, I., Samaşcă, G., & Burz, C. C. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.11.010 · Cited by 88
Aspirin Use and Reduced Risk of Pancreatic Cancer
Risch, H. A., Lu, L., Streicher, S. A., Wang, J., Zhang, W., Ni, Q., Kidd, M. S., Yu, H., & Gao, Y.-T. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0508 · Cited by 75
Disrupting Cytokine Signaling in Pancreatic Cancer
Wu, C. S.-Y., Fernández, S., Criswell, T., Chidiac, T. A., Guttridge, D. C., Villalona-Calero, M. A., & Bekaii‐Saab, T. (2013) · Pancreas · doi:10.1097/mpa.0b013e318279b87f · Cited by 70
Basso, D., Gnatta, E., Padoan, A., Fogar, P., Furlanello, S., Aita, A., Bozzato, D., Zambon, C., Arrigoni, G., Frasson, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20863 · Cited by 70
Self-citationKrintel, S. B., Dehlendorff, C., Hetland, M. L., Hørslev‐Petersen, K., Andersen, K. K., Junker, P., Pødenphant, J., Ellingsen, T., Ahlquist, P., Lindegaard, H., et al. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2015.30 · Cited by 68
Jiao, L., Chen, L., White, D. L., Tinker, L. F., Chlebowski, R. T., Horn, L. V., Richardson, P., Lane, D. S., Sangi‐Haghpeykar, H., & El‐Serag, H. B. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx117 · Cited by 63
Basso, D., Fogar, P., Falconi, M., Fadi, E., Sperti, C., Frasson, C., Greco, E., Tamburrino, D., Teolato, S., Moz, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054824 · Cited by 57
Self-citationNomura, A., Gupta, V. K., Dauer, P., Sharma, N., Dudeja, V., Merchant, N. B., Saluja, A. K., & Banerjee, S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0221 · Cited by 57
Awoyemi, A., Trøseid, M., Arnesen, H., Solheim, S., & Seljeflot, I. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0360-3 · Cited by 55
Sheikh, A. A., Vimalachandran, D., Thompson, C. C., Jenkins, R. E., Nedjadi, T., Shekouh, A., Campbell, F., Dodson, A. R., Prime, W., Crnogorac‐Jurcevic, T., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700072 · Cited by 54
Ang, C. W., Nedjadi, T., Sheikh, A. A., Tweedle, E. M., Tonack, S., Honap, S., Jenkins, R. E., Park, B. K., Schwarte‐Waldhoff, I., Khattak, I., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq137 · Cited by 53
Ciechomska, M., Bonek, K., Merdas, M., Zarecki, P., Świerkot, J., Głuszko, P., Bogunia‐Kubik, K., & Maśliński, W. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0513-y · Cited by 53
Serum Cytokine Profile in Patients With Pancreatic Cancer
Torres, C., Perales, S., Alejandre, M. J., Iglesias, J., Palomino‐Morales, R., Martín, M., Caba, O., Prados, J. C., Aránega, A., Delgado, J. R., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000155 · Cited by 51
Feng, R., Morine, Y., Ikemoto, T., Imura, S., Iwahashi, S., Saito, Y., & Shimada, M. (2018) · Cancer Science · doi:10.1111/cas.13694 · Cited by 51
Circulating myeloid-derived suppressor cells in patients with pancreatic cancer
Xu, X., Hu, J., Wang, M., Peng, F., Tian, R., Guo, X., Xie, Y., & Qin, R. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60413-1 · Cited by 50
Wang, Y., Jin, G., Li, Q., Wang, Z., Hu, W., Li, P., Li, S.-D., Wu, H., Kong, X., Gao, J., et al. (2016) · Journal of Cancer · doi:10.7150/jca.15786 · Cited by 48
Barbarroja, N., Castro, M. C., Perez-Sanchez, C., Ruiz‐Limón, P., Aguirre, M. A., Escudero‐Contreras, A., Jiménez, Y., Carretero, R. M., Font, P., Collantes‐Estévez, E., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-eular.4103 · Cited by 46
Exploring the microbiota to better understand gastrointestinal cancers physiology
Panebianco, C., Potenza, A., Andriulli, A., & Pazienza, V. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-1163 · Cited by 46
Serum LBP Is Associated with Insulin Resistance in Women with PCOS
Zhu, Q., Huang, Z., Zhang, A., Gao, R., Yang, S., Zhao, C., Wang, Y., Hu, J., Goswami, R., Gong, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145337 · Cited by 45
Koyanagi, Y. N., Matsuo, K., Ito, H. M., Tamakoshi, A., Sugawara, Y., Hidaka, A., Wada, K., Oze, I., Kitamura, Y. T., Liu, R., et al. (2017) · Journal of Epidemiology · doi:10.2188/jea.je20160193 · Cited by 44
Ishii, N., Araki, K., Yokobori, T., Hagiwara, K., Gantumur, D., Yamanaka, T., Handa, T., Tsukagoshi, M., Igarashi, T., Watanabe, A., et al. (2018) · Cancer Science · doi:10.1111/cas.13847 · Cited by 44
Basso, D., Bozzato, D., Padoan, A., Moz, S., Zambon, C., Fogar, P., Greco, E., Scorzeto, M., Simonato, F., Navaglia, F., et al. (2014) · Inflammation and Cell Signaling · doi:10.1186/1478-811x-12-20 · Cited by 43
Self-citationCan baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
on behalf of all SRU investigators, Cuppen, B. V. J., Rossato, M., Fritsch-Stork, R. D. E., Concepcion, A. N., Schenk, Y., Bijlsma, J. W. J., Radstake, T. R. D. J., & Lafeber, F. P. J. G. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1085-z · Cited by 38
Greco, E., Basso, D., Fogar, P., Mazza, S., Navaglia, F., Zambon, C., Falda, A., Pedrazzoli, S., Ancona, E., & Plebani, M. (2005) · The International Journal of Biological Markers · doi:10.1177/172460080502000406 · Cited by 36
Self-citationChopra, M., Lang, I., Salzmann, S., Pachel, C., Kraus, S., Bäuerlein, C. A., Brede, C., Garrote, A.-L. J., Mattenheimer, K., Ritz, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075737 · Cited by 36
Prognostic role of platelet to lymphocyte ratio in pancreatic cancers
Li, W., Tao, L., Lu, M., & Xiu, D. (2018) · Medicine · doi:10.1097/md.0000000000009616 · Cited by 32
Metabolic influence on the differentiation of suppressive myeloid cells in cancer
Porta, C., Marino, A., Consonni, F. M., Bleve, A., Mola, S., Storto, M., Riboldi, E., & Sica, A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy088 · Cited by 32
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression
Hawa, Z., Haque, I., Ghosh, A., Banerjee, S., Harris, L., & Banerjee, S. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060809 · Cited by 24
Papaconstantinou, I. G., Kapizioni, C., Legaki, E., Xourgia, E., Karamanolis, G. P., Gklavas, A., & Gazouli, M. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i4.193 · Cited by 23
Basso, D., Greco, E., Padoan, A., Fogar, P., Scorzeto, M., Fadi, E., Bozzato, D., Moz, S., Navaglia, F., Zambon, C., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22355 · Cited by 19
Self-citationMoz, S., Basso, D., Padoan, A., Bozzato, D., Fogar, P., Zambon, C., Pelloso, M., Sperti, C., de Kreutzenberg, S. V., Pasquali, C., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.018 · Cited by 19
Self-citationTumor-Promoting Inflammatory Networks in Pancreatic Neoplasia: Another Reason to Loathe Kras
Vonderheide, R. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.020 · Cited by 17
Moz, S., Basso, D., Bozzato, D., Galozzi, P., Navaglia, F., Negm, O. H., Arrigoni, G., Zambon, C., Padoan, A., Tighe, P. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12068 · Cited by 17
Self-citationDiet boosts the effectiveness of a cancer drug
Pollak, M. (2018) · Nature · doi:10.1038/d41586-018-05871-x · Cited by 7
Cited by
Yang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 494
Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Das, S., Shapiro, B., Vucic, E. A., Vogt, S., & Bar-Sagi, D. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2080 · Cited by 366
Metabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 328
Nagata, N., Nishijima, S., Kojima, Y., Hisada, Y., Imbe, K., Miyoshi-Akiyama, T., Suda, W., Kimura, M., Aoki, R., Sekine, K., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.054 · Cited by 209
Husain, K., Villalobos-Ayala, K., Laverde, V., Vazquez, O. A., Miller, B., Kazim, S., Blanck, G., Hibbs, M. L., Krystal, G., Elhussin, I., et al. (2022) · Cancers · doi:10.3390/cancers14153613 · Cited by 26
Metadata
- Authors
- Padoan, A., Plebani, M., & Basso, D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-05
- Volume
- 20
- Issue
- 3
- Pages
- 676
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2913836031
- Cited by
- 358
- References
- 110
- FWCI
- 13.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.